Hello! Just to let you know that we use non-essential cookies (including analytics and third party cookies) to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential for our platform to work and help us to provide you with the best experience possible. You can accept or reject our non-essential cookies and change your mind at any time. To learn more, please read our cookies policy.

Update cookie preferences
Skip to content

Cure Parkinson's Trust (The)

We have one bold aim: to cure Parkinson's. We fund inspirational scientists and innovative research to uncover treatments that could slow, stop or reverse the condition. Our work inspires patients to engage with their condition and take an active role in the worldwide effort to find a cure.

www.cureparkinsons.org.uk Fundraise for us

020 7487 3892

Registered charity no. 1111816

Member since June 2018

Latest News

Diabetes drug is a potential disease-modifying therapy

Diabetes drug is a potential disease-modifying therapy

A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson’s disease, a new University College London-led study suggests, paving the way for further research to define its efficacy and safety.

The study was conducted at UCL in collaboration with The Cure Parkinson’s Trust and researchers from the National Institute on Aging, and was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), found that people with Parkinson’s who injected themselves each week with exenatide for one year performed better in movement (motor) tests than those who injected a placebo.

“This is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the symptoms. With existing treatments, we can relieve most of the symptoms for some years, but the disease continues to worsen. This is the strongest evidence we have so far that a drug could do more than provide symptom relief for Parkinson’s disease.”

- Professor Tom Foltynie (UCL Institute of Neurology).

To find out more about this drug visit www.cureparkinsons.org.uk/bydureonresults and to learn more about other trials we are involved in visit www.cureparkinsons.org.uk/trials-repurposed-drugs